Study: Enzyme could be potential drug target for rare leukemia

09/17/2008 | Reuters

U.S. scientists found that blocking the enzyme glycogen synthase kinase, which can combat certain cancers, by using a drug for bipolar disorder helped prolong the life of mice with mixed-lineage leukemia, a rare form of disease that affects infants. The finding may prove useful in developing "better inhibitors that can be administered long term," one of the researchers said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD